Biotech Intel



Aloe Finance Inc.
Latest Comments
image_pdfimage_print

Scythian to treat the secondary effects of traumatic brain injuries with cannabinoids


August 14, 2017
| August 14, 2017 | 2 Comments

Scythian BioSciences Corp. (TSXV: SCYB), which began trading on the TSXV last week under the symbol SCYB, is developing cannabinoid-based drugs to […]


BlueOcean’s Pure Polar on its way to Europe


June 21, 2017
| June 21, 2017

BlueOcean NutraSciences Inc. (TSXV: BOC) (“BlueOcean”) announced that it has received its first order from a distributor in the European Union […]


IntelGenX on the way to take some of the $16bn thin films market


June 08, 2017
| June 08, 2017

As a technophile, IntelGenX Technologies Corp. (TSXV: IGX | OTCQX: IGXT) (“IntelGenX”) have always intrigued me. The company developed a […]


Commercialising graphene: Graphene oxide biosensors


April 24, 2017
| April 24, 2017 | 3 Comments

What is a biosensor? Ladies, bear with me for a minute. Prostate cancer is the most common cancer in men […]


BlueOcean in position to tap three huge markets with antioxidant


February 21, 2017
| February 21, 2017

BlueOcean NutraSciences Inc. (TSXV: BOC) announced that it will restart its dormant algae gas infusion subsidiary targeting commercial Omega-3 and […]


IntelGenx takes migraine medication “head-on”


December 22, 2016
| December 22, 2016 | 1 Comment

The term a “bitter pill to swallow” may have been used as a figure of speech since the 17th century, […]


BlueOcean Nutraceuticals Inc.